- RNA–RNA and RNA–protein interactions are fundamental molecular processes that regulate gene expression, RNA processing, cellular organization, and many biological activities. RNA molecules rarely function independently; instead, they interact with other RNA molecules and proteins to form regulatory networks and functional complexes. These interactions influence RNA stability, splicing, transport, localization, translation, degradation, and gene silencing. Understanding these molecular relationships is an important part of molecular biology, functional genomics, and bioinformatics because they help explain how genetic information is regulated after transcription.
- RNA–RNA interactions occur when two or more RNA molecules recognize and bind to complementary or partially complementary nucleotide sequences. These interactions are generally mediated by hydrogen bonding between complementary bases, although RNA secondary and tertiary structures also influence their formation and stability. RNA–RNA interactions can occur between messenger RNAs, microRNAs, long non-coding RNAs, small interfering RNAs, circular RNAs, and other RNA classes. Depending on their sequence complementarity and structural context, these interactions may promote RNA degradation, inhibit translation, regulate RNA processing, or influence RNA localization.
- One of the best-known examples of RNA–RNA interaction is the interaction between microRNAs (miRNAs) and their target messenger RNAs. MicroRNAs are short regulatory RNAs, generally around 20–24 nucleotides long, that associate with Argonaute proteins to form the RNA-induced silencing complex (RISC). The miRNA guides this complex to complementary sequences, commonly located in the 3′ untranslated region (3′ UTR) of target mRNAs. In animals, recognition often depends strongly on a short region called the seed sequence. Binding can reduce translation or promote deadenylation, decapping, and degradation of the target mRNA. In some cases, extensive complementarity allows direct cleavage of the target RNA.
- Small interfering RNAs (siRNAs) also participate in RNA–RNA recognition and gene silencing. They are usually generated from double-stranded RNA and incorporated into Argonaute-containing silencing complexes. The guide strand directs the complex toward complementary RNA molecules, often resulting in cleavage and degradation of the target. This process, known as RNA interference (RNAi), is important in experimental gene silencing, antiviral defense, and the regulation of transposable elements. RNAi is also widely used in functional genomics to investigate the biological roles of individual genes.
- Long non-coding RNAs (lncRNAs) can interact with messenger RNAs and other RNA molecules through complementary sequences or RNA structural elements. These interactions may influence mRNA stability, translation, localization, and degradation. Some lncRNAs act as molecular decoys by binding miRNAs and reducing their availability to interact with target mRNAs. This mechanism is often described as the competing endogenous RNA (ceRNA) hypothesis. However, the biological importance of individual ceRNA interactions depends on factors such as RNA abundance, binding affinity, cellular localization, and the relative concentrations of competing molecules. Not every predicted lncRNA–miRNA interaction produces a meaningful regulatory effect in living cells.
- Circular RNAs (circRNAs) are another class of RNA molecules that can participate in RNA–RNA interactions. Because they have covalently closed circular structures without conventional free 5′ and 3′ ends, many circRNAs are relatively resistant to exonuclease-mediated degradation. Some contain binding sites for miRNAs and may influence miRNA availability, although this function is not universal and depends on their abundance and binding-site content. CircRNAs can also interact with RNA-binding proteins and influence transcription, RNA processing, and other regulatory activities.
- RNA–RNA interactions also occur during RNA processing and maturation. Small nuclear RNAs (snRNAs) interact with pre-mRNA and other snRNAs within the spliceosome, a large molecular complex responsible for removing introns from precursor messenger RNA. These interactions help identify splice sites and coordinate the chemical reactions required for intron removal and exon joining. Small nucleolar RNAs (snoRNAs) interact with ribosomal RNA and guide specific chemical modifications, including 2′-O-methylation and pseudouridylation. In addition, RNA molecules can form intermolecular duplexes that influence RNA folding, stability, and regulatory activity.
- RNA–protein interactions involve the binding of RNA molecules to proteins that recognize particular RNA sequences, structures, or chemical modifications. These interactions are essential because proteins control many aspects of RNA metabolism. RNA-binding proteins (RBPs) contain specialized domains that recognize RNA molecules, including RNA recognition motifs (RRMs), K-homology (KH) domains, zinc-finger domains, and double-stranded RNA-binding domains. Some proteins recognize specific nucleotide sequences, whereas others bind particular RNA structures or modified nucleotides. Their interactions can be highly selective and may change according to cellular conditions.
- RNA-binding proteins regulate pre-mRNA splicing by interacting with exonic and intronic regulatory sequences. Serine/arginine-rich (SR) proteins commonly promote splice-site recognition and exon inclusion, whereas heterogeneous nuclear ribonucleoproteins (hnRNPs) can influence exon inclusion or exclusion depending on their binding sites and cellular context. These proteins help determine which transcript isoforms are produced from individual genes. Changes in RBP activity can therefore alter transcript diversity and contribute to tissue-specific gene expression and disease-associated splicing abnormalities.
- RNA–protein interactions are also important for RNA transport and localization. Newly synthesized RNA molecules often associate with proteins to form ribonucleoprotein particles (RNPs). These complexes protect RNA during transport and direct it to particular cellular locations. For example, selected messenger RNAs are transported to specific regions of neurons, where their localized translation supports synaptic function. RNA-binding proteins also help regulate the localization of transcripts in developing embryos, muscle cells, and other specialized tissues. These mechanisms allow cells to control where proteins are produced rather than relying exclusively on where the corresponding genes are transcribed.
- Another major function of RNA–protein interactions is the regulation of translation. Messenger RNAs associate with initiation factors, ribosomal proteins, and other translation-associated proteins to form complexes that support protein synthesis. Regulatory proteins can bind to the 5′ or 3′ untranslated regions of mRNAs and influence ribosome recruitment, translation initiation, or elongation. Some RNA-binding proteins inhibit translation, whereas others promote it. These mechanisms are particularly important during cellular stress, development, and changes in nutrient availability.
- RNA–protein interactions also influence RNA stability and degradation. Some RBPs protect transcripts by preventing access to nucleases, while others recruit enzymes that promote deadenylation, decapping, or exonucleolytic degradation. For example, the protein HuR can stabilize selected mRNAs, whereas members of the tristetraprolin family can promote the degradation of transcripts containing specific AU-rich elements. RNA-binding proteins also participate in RNA quality-control pathways, including nonsense-mediated mRNA decay (NMD), which removes many transcripts containing premature termination codons.
- Chemical RNA modifications provide additional opportunities for RNA–protein recognition. N6-methyladenosine (m6A), 5-methylcytosine (m5C), pseudouridine, and other modifications can alter RNA structure or create recognition sites for particular proteins. Proteins that recognize modified RNA molecules are often called RNA modification readers. For example, YTH-domain proteins recognize m6A-modified RNA and can influence its processing, translation, localization, or degradation. These interactions form an important part of epitranscriptomic regulation, connecting chemical changes in RNA with its biological activity.
- RNA–protein interactions are not limited to individual RNA molecules. Many cellular processes depend on large ribonucleoprotein complexes containing multiple RNAs and proteins. The ribosome is a major example, consisting of ribosomal RNAs and numerous proteins that coordinate protein synthesis. The spliceosome contains several snRNAs and associated proteins that process pre-mRNA. The signal recognition particle (SRP) contains RNA and proteins involved in directing newly synthesized proteins to the endoplasmic reticulum or bacterial membrane. Telomerase contains an RNA component that provides a template for extending chromosome ends, together with a catalytic protein component. These complexes demonstrate how RNA and proteins cooperate to perform complex molecular functions.
- RNA–RNA and RNA–protein interactions can be investigated using several experimental techniques. RNA immunoprecipitation (RIP) identifies RNA molecules associated with a particular RNA-binding protein. In this method, the protein of interest is isolated using a specific antibody, and associated RNAs are recovered and analyzed. RIP followed by sequencing (RIP-seq) provides a broader view of the RNA molecules associated with the selected protein. However, conventional RIP may detect indirect associations because proteins and RNAs can be part of larger molecular complexes.
- Crosslinking and immunoprecipitation (CLIP) methods provide more direct evidence of RNA–protein binding by using ultraviolet light to crosslink interacting molecules before immunoprecipitation. High-throughput sequencing of recovered RNA fragments can identify protein-binding sites across the transcriptome. Important approaches include HITS-CLIP, PAR-CLIP, iCLIP, and eCLIP. These techniques help identify RNA-binding sites, characterize protein-specific RNA recognition, and investigate regulatory networks. CLIP-based methods require careful experimental controls because crosslinking efficiency, antibody specificity, and sequencing depth can affect the results.
- RNA–RNA interactions can be investigated using complementary experimental methods. RNA pull-down assays can identify RNA molecules or proteins associated with a selected RNA, while antisense oligonucleotide-based approaches can help capture interacting RNA partners. RNA antisense purification (RAP), capture hybridization analysis of RNA targets (CHART), and chromatin isolation by RNA purification (ChIRP) are methods used to investigate RNA interactions with other molecules, particularly when studying long non-coding RNAs. For miRNA–mRNA interactions, reporter assays, miRNA inhibition or overexpression, and targeted validation can help establish whether predicted interactions have functional consequences.
- Bioinformatics plays a major role in predicting and interpreting RNA–RNA and RNA–protein interactions. RNA sequence complementarity and secondary structure can be analyzed using tools such as RNAhybrid, IntaRNA, and RNAup. These programs help predict potential interactions between RNA molecules by considering sequence pairing and thermodynamic properties. ViennaRNA and RNAstructure provide tools for RNA secondary-structure prediction and analysis. For miRNA target prediction, resources and tools such as TargetScan, miRanda, PITA, and miRDB are commonly used. These predictions should be interpreted cautiously because computationally predicted binding does not necessarily indicate a functional interaction in vivo.
- For RNA–protein interaction analysis, computational approaches include sequence-based prediction, structural modeling, machine learning, and analysis of experimental binding data. RBPmap can help identify potential RNA-binding protein recognition sites, while ATtRACT provides information about RNA-binding proteins and their binding motifs. oRNAment is another resource for RNA-binding protein motifs. ENCORI (starBase) integrates experimentally supported and computationally predicted RNA interaction information, including miRNA–target and RBP–RNA relationships. POSTAR provides information on post-transcriptional regulatory interactions, while NPInter contains experimentally supported interactions involving non-coding RNAs and other molecules.
- Structural bioinformatics can further explain how RNA and proteins interact at the molecular level. RNA secondary-structure prediction, protein structure prediction, molecular docking, and molecular dynamics simulations can help investigate potential binding interfaces and interaction stability. Experimental structural techniques, including X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and cryo-electron microscopy (cryo-EM), provide detailed information about RNA–protein complexes. These methods are particularly valuable for understanding the molecular mechanisms of ribosomes, spliceosomes, RNA-binding domains, and other ribonucleoprotein assemblies.
- RNA–RNA and RNA–protein interactions have important applications in medicine, biotechnology, and agriculture. In medicine, abnormal interactions can contribute to cancer, neurological disorders, viral infections, and genetic diseases. Therapeutic approaches based on antisense oligonucleotides, siRNAs, and other RNA-targeting technologies can modify RNA interactions and influence gene expression. In biotechnology, RNA–protein interactions are important for developing RNA-based therapeutics, improving RNA stability, and controlling protein production. In plant and animal research, these interactions can help explain regulatory mechanisms involved in development, immunity, reproduction, metabolism, and environmental adaptation.
- In animal breeding and livestock genomics, RNA interaction networks may contribute to differences in growth, muscle development, milk production, fertility, immune response, feed efficiency, and stress tolerance. Regulatory RNAs and RNA-binding proteins can influence the expression of genes associated with economically important traits. Integrating RNA interaction data with transcriptomics, genomics, proteomics, and quantitative genetics may help identify molecular pathways involved in trait variation and biological adaptation.
- Despite their importance, studying RNA–RNA and RNA–protein interactions presents several challenges. Computational predictions can produce false-positive results because RNA folding, cellular localization, molecular concentration, and biological context are difficult to model completely. Experimental methods may be influenced by crosslinking efficiency, antibody specificity, sample preparation, and technical variation. Some interactions are transient or occur only in particular tissues or environmental conditions, making them difficult to detect. In addition, identifying a physical interaction does not automatically establish its biological function. Combining computational predictions with experimental validation and functional studies is therefore essential.
- Overall, RNA–RNA and RNA–protein interactions form an extensive regulatory network that controls RNA metabolism and gene expression. Through sequence recognition, structural interactions, ribonucleoprotein complex formation, and chemical modification-dependent binding, RNA molecules and proteins coordinate transcriptional and post-transcriptional processes. Their investigation using RNA sequencing, RIP-seq, CLIP-seq, RNA interaction assays, structural biology, and computational prediction provides important insights into molecular regulation, disease mechanisms, biotechnology, and animal genomics.